DR. JOHN M. SULLIVAN, M.D. PH.D.
Medical Practice in Buffalo, NY
License number
New York 207651
Category
Medical Practice
Type
Ophthalmology
Address
Address
2
3495 Ms151 BUILDING 20, Buffalo, NY 14215
175 Kenton Pl, Hamburg, NY 14075
175 Kenton Pl, Hamburg, NY 14075
Phone
(716) 862-6533
(716) 862-6526 (Fax)
(716) 649-4785
(716) 862-6526 (Fax)
(716) 649-4785
Personal information
See more information about JOHN M. SULLIVAN at radaris.comName
Address
Phone
5020 67Th St, Woodside, NY 11377
5016 State Route 14A, Geneva, NY 14456
507 Willow Grove Rd, Stony Point, NY 10980
5056 Broadway APT 5, New York, NY 10034
505 W 54Th St APT 1112, New York, NY 10019
Organization information
See more information about JOHN M. SULLIVAN at bizstanding.comDr. John M. Sullivan, MD
3495 Bailey Ave, Buffalo, NY 14215
Industry:
Medical Doctor's Office, Nonclassifiable Establishments, Whol Hardware
Medical Doctors:
Edward Fine (Medical Doctor),Nancy R. Colligan (Medical Doctor),John Batista Grippi (Medical Doctor),...
Professional information
See more information about JOHN M. SULLIVAN at trustoria.com
Final Documents Manager At M&Amp;T Bank
Final Documents Manager At M&Amp;T Bank
Position:
Final Documents Manager at M&T Bank
Location:
Buffalo/Niagara, New York Area
Industry:
Banking
Work:
M&T Bank
- Buffalo, NY since Feb 2013
-
Final Documents Manager
M&T Bank
Jan 2011 - Feb 2013
-
Final Documents Group Leader
M&T Bank
Sep 2009 - Jan 2011
-
Sr. Mortgage Servicing Rep.
Education:
Medaille College 2006 - 2008
MBA, Business Administration State University of New York at Buffalo 2000 - 2004
BA, Political Science
MBA, Business Administration State University of New York at Buffalo 2000 - 2004
BA, Political Science
John Sullivan, Buffalo NY
John Sullivan, Buffalo NY
Work:
Va Western Ny Healthcare
3495 Bailey Ave, Buffalo, NY 14215
3495 Bailey Ave, Buffalo, NY 14215
Dr. John M Sullivan, Buffalo NY - MD (Doctor of Medicine)
Dr. John M Sullivan, Buffalo NY - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
3495 Bailey Ave SUITE 20, Buffalo 14215
(716) 862-6533 (Phone), (716) 862-6526 (Fax)
UPSTATE NEW YORK HCS
3495 Bailey Ave SUITE 2ND, Buffalo 14215
(716) 862-3145 (Phone), (716) 862-8779 (Fax)
1000 Wall St, Ann Arbor 48105
(716) 862-6533 (Phone), (716) 862-6526 (Fax)
UPSTATE NEW YORK HCS
3495 Bailey Ave SUITE 2ND, Buffalo 14215
(716) 862-3145 (Phone), (716) 862-8779 (Fax)
1000 Wall St, Ann Arbor 48105
Certifications:
Ophthalmology, 1955
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Mount Sinai School of Medicine
Graduated: 1987
Bishop De Goesbriand Hosp
Manhattan Eet Hosp
Mount Sinai School of Medicine
Graduated: 1987
Bishop De Goesbriand Hosp
Manhattan Eet Hosp
Method For Identification Of Polynucleotides Capable Of Cleaving Target Mrna Sequences
Method For Identification Of Polynucleotides Capable Of Cleaving Target Mrna Sequences
US Patent:
8252527, Aug 28, 2012
Filed:
Feb 19, 2008
Appl. No.:
12/070561
Inventors:
John M. Sullivan - Hamburg NY, US
Edwin H. Yau - Amherst NY, US
Edwin H. Yau - Amherst NY, US
Assignee:
The Research Foundation of State University of New York - Amherst NY
International Classification:
C12Q 1/68
US Classification:
435 6, 435325, 435375, 536 245, 536 2431, 536 241
Abstract:
Provided are methods for identifying a polynucleotide that can reduce the level of a target mRNA. The method can be performed by providing cells that express an RNA polynucleotide that contains a target mRNA sequence, an internal ribosome entry sequence (IRES) and a sequence encoding a secreted reporter protein; introducing to the cells a test polynucleotide, and measuring activity of the secreted reporter protein. A reduction in secreted reporter protein activity relative to a control cell into which the test polynucleotide has not been introduced is indicative that the test polynucleotide is capable of reducing the level of the target mRNA in the cells. The method is adaptable for high throughput screening methods and is suited for identifying polynucleotides that can catalyze cleavage of target mRNA and/or act on target mRNA through and antisense or RNAi mechanism.